{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:01:01Z","timestamp":1791266461877,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ejps.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T03:10:42Z","timestamp":1318648242000},"page":"475-481","source":"Crossref","is-referenced-by-count":90,"title":["Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice"],"prefix":"10.1016","volume":"45","author":[{"given":"Suzanne M.","family":"Bal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Sl\u00fctter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Verheul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke A.","family":"Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Jiskoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2011.10.003_b0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2006.06.086","article-title":"N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model","volume":"25","author":"Amidi","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ejps.2011.10.003_b0010","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.4049\/jimmunol.170.3.1586","article-title":"Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses","volume":"170","author":"Anjuere","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ejps.2011.10.003_b0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.2002.01988.x","article-title":"Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice","volume":"130","author":"Aspord","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"2\u20134","key":"10.1016\/j.ejps.2011.10.003_b0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.vetimm.2009.06.005","article-title":"Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B","volume":"132","author":"Ayalew","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"9","key":"10.1016\/j.ejps.2011.10.003_b0025","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s11095-010-0182-y","article-title":"Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations","volume":"27","author":"Bal","year":"2010","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ejps.2011.10.003_b0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.vaccine.2010.11.061","article-title":"Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination","volume":"29","author":"Bal","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ejps.2011.10.003_b0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2009.11.018","article-title":"Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations","volume":"142","author":"Bal","year":"2010","journal-title":"J. Control Release"},{"issue":"6","key":"10.1016\/j.ejps.2011.10.003_b0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/intimm\/12.6.737","article-title":"CpG motifs induce Langerhans cell migration in vivo","volume":"12","author":"Ban","year":"2000","journal-title":"Int. Immunol."},{"issue":"25\u201326","key":"10.1016\/j.ejps.2011.10.003_b0045","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/S0264-410X(03)00305-0","article-title":"The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines","volume":"21","author":"Baudner","year":"2003","journal-title":"Vaccine"},{"issue":"7085","key":"10.1016\/j.ejps.2011.10.003_b0050","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2011.10.003_b0055","doi-asserted-by":"crossref","unstructured":"Bogefors, J., Rydberg, C., Uddman, R., Fransson, M., Mansson, A., Benson, M., Adner, M., Cardell, L.O. 2010. Nod1, Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis? Allergy.","DOI":"10.1111\/j.1398-9995.2009.02315.x"},{"issue":"21\u201322","key":"10.1016\/j.ejps.2011.10.003_b0060","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/S0264-410X(02)00215-3","article-title":"Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity","volume":"20","author":"Chen","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ejps.2011.10.003_b0065","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1542\/peds.2006-3176","article-title":"Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children","volume":"119","author":"Chiu","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ejps.2011.10.003_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0882-4010(02)00194-8","volume":"34","author":"Conlan","year":"2003","journal-title":"Microb. Pathog."},{"issue":"29\u201330","key":"10.1016\/j.ejps.2011.10.003_b0075","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.vaccine.2004.03.047","article-title":"Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins","volume":"22","author":"de Jonge","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ejps.2011.10.003_b0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/194589240501900303","article-title":"Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway","volume":"19","author":"Dong","year":"2005","journal-title":"Am. J. Rhinol."},{"issue":"8","key":"10.1016\/j.ejps.2011.10.003_b0085","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/10611860903119656","article-title":"Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response","volume":"17","author":"Fischer","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2011.10.003_b0090","doi-asserted-by":"crossref","unstructured":"Flood, E., Block, S., Hall, M., Rousculp, M., Divino, V., Toback, S., Mahadevia, P. 2010. Children\u2019s perceptions of influenza illness and preferences for influenza vaccine. J. Pediat. Health Care.","DOI":"10.1016\/j.pedhc.2010.04.007"},{"issue":"9629","key":"10.1016\/j.ejps.2011.10.003_b0095","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(08)60839-9","article-title":"Use of a patch containing heat-labile toxin from Escherichia coli against travellers\u2019 diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial","volume":"371","author":"Frech","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejps.2011.10.003_b0100","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4049\/jimmunol.177.2.1007","article-title":"Differential pattern recognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subsets","volume":"177","author":"Hubert","year":"2006","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.ejps.2011.10.003_b0105","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.4049\/jimmunol.161.11.5952","article-title":"Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1\/Th2 help for virus-specific immune responses in reproductive tissues","volume":"161","author":"Imaoka","year":"1998","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.ejps.2011.10.003_b0110","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with intradermal injection of influenza vaccine","volume":"351","author":"Kenney","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejps.2011.10.003_b0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.003_b0120","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/IAI.74.1.694-702.2006","article-title":"A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity","volume":"74","author":"Lee","year":"2006","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.ejps.2011.10.003_b0125","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1128\/IAI.00563-09","article-title":"Nod1\/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure","volume":"77","author":"Loving","year":"2009","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.ejps.2011.10.003_b0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2174\/1566524054863898","article-title":"Targeted vaccine adjuvants based on modified cholera toxin","volume":"5","author":"Lycke","year":"2005","journal-title":"Curr. Mol. Med."},{"issue":"24","key":"10.1016\/j.ejps.2011.10.003_b0135","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/S0264-410X(00)00055-4","article-title":"Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)","volume":"18","author":"Matsuo","year":"2000","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ejps.2011.10.003_b0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1615\/CritRevImmunol.v28.i4.20","article-title":"Understanding how lipopolysaccharide impacts CD4 T-cell immunity","volume":"28","author":"McAleer","year":"2008","journal-title":"Crit. Rev. Immunol."},{"issue":"27","key":"10.1016\/j.ejps.2011.10.003_b0145","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.vaccine.2009.03.069","article-title":"The mast cell activator compound 48\/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen","volume":"27","author":"McGowen","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejps.2011.10.003_b0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0022-202X.2003.22116.x","article-title":"Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells","volume":"122","author":"Mitsui","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.ejps.2011.10.003_b0155","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.0818-9641.2004.01280.x","article-title":"Adjuvant synergy: the effects of nasal coadministration of adjuvants","volume":"82","author":"Moschos","year":"2004","journal-title":"Immunol. Cell Biol."},{"issue":"9","key":"10.1016\/j.ejps.2011.10.003_b0160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2011.10.003_b0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.14.1.275","article-title":"Antigen sampling across epithelial barriers and induction of mucosal immune responses","volume":"14","author":"Neutra","year":"1996","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.003_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymeth.2006.05.017","article-title":"Microparticle-based technologies for vaccines","volume":"40","author":"O\u2019Hagan","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.ejps.2011.10.003_b0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/0-387-24180-9_2","article-title":"Toll-like receptors: linking innate and adaptive immunity","volume":"560","author":"Pasare","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"issue":"12","key":"10.1016\/j.ejps.2011.10.003_b0180","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.4049\/jimmunol.174.12.7558","article-title":"TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells","volume":"174","author":"Patel","year":"2005","journal-title":"J. Immunol."},{"issue":"17\u201319","key":"10.1016\/j.ejps.2011.10.003_b0185","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non-toxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.ejps.2011.10.003_b0190","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/S0264-410X(99)00440-5","article-title":"An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems","volume":"18","author":"Puri","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ejps.2011.10.003_b0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-0463.2000.d01-42.x","article-title":"Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and\/or of co-administration with free toxin as adjuvant","volume":"108","author":"Rask","year":"2000","journal-title":"APMIS"},{"issue":"13","key":"10.1016\/j.ejps.2011.10.003_b0200","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.vaccine.2008.01.030","article-title":"TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses","volume":"26","author":"Schlosser","year":"2008","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.ejps.2011.10.003_b0205","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1073\/pnas.0912817107","article-title":"Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants","volume":"107","author":"Sen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ejps.2011.10.003_b0210","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1084\/jem.194.11.1597","article-title":"Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue","volume":"194","author":"Shimoda","year":"2001","journal-title":"J. Exp. Med."},{"issue":"2\u20133","key":"10.1016\/j.ejps.2011.10.003_b0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0144-8617(98)00009-5","article-title":"Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride","volume":"36","author":"Sieval","year":"1998","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.ejps.2011.10.003_b0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2011.02.007","article-title":"Adjuvant effect of cationic liposomes and CpG depends on administration route","volume":"154","author":"Sl\u00fctter","year":"2011","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.ejps.2011.10.003_b0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2010.06.009","article-title":"Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination","volume":"148","author":"Sl\u00fctter","year":"2010","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2011.10.003_b0230","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2010.06.121","article-title":"Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen","volume":"28","author":"Sl\u00fctter","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ejps.2011.10.003_b0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2009.05.011","article-title":"Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination","volume":"138","author":"Sl\u00fctter","year":"2009","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.ejps.2011.10.003_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2009.02321.x","article-title":"Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit","volume":"71","author":"Sun","year":"2010","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.ejps.2011.10.003_b0245","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/hv.4.5.6438","article-title":"Vaccine adjuvants: the dream becomes real","volume":"4","author":"Tagliabue","year":"2008","journal-title":"Hum. Vaccine"},{"issue":"7","key":"10.1016\/j.ejps.2011.10.003_b0250","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/1521-4141(200007)30:7<1939::AID-IMMU1939>3.0.CO;2-#","article-title":"Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity","volume":"30","author":"Tighe","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.ejps.2011.10.003_b0255","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ejps.2011.10.003_b0260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1631\/jzus.B0730029","article-title":"A synthetic Toll-like receptor 2 ligand decreases allergic immune responses in a mouse rhinitis model sensitized to mite allergen","volume":"9","author":"Zhou","year":"2008","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"4","key":"10.1016\/j.ejps.2011.10.003_b0265","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.168.4.1796","article-title":"Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses","volume":"168","author":"Zuercher","year":"2002","journal-title":"J. Immunol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711003447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711003447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T13:26:56Z","timestamp":1686403616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098711003447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0928098711003447"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2011.10.003","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}